J Korean Med Assoc.  2017 Nov;60(11):893-898. 10.5124/jkma.2017.60.11.893.

Screening strategy for colorectal cancer according to risk

Affiliations
  • 1Hanyang University Guri Hospital, Guri-si, Korea. hands@hanyang.ac.kr

Abstract

Incidence and prevalence of colorectal cancer is increasing worldwide. It related with Westernized life style change, easier access to endoscopic facilities and organized cancer prevention program. The pathogenesis of colorectal cancer is multifactorial, most of cases are sporadic. The risk of colorectal cancer is increasing by age, sex, previous history of colon polyps and cancer, family history of colorectal cancer, hereditary colorectal cancer syndrome, and other modifiable conditions. It is best to screen with organized colorectal cancer screening program for average risk patients at the age of 50 and modify screening strategy by risk factors.

Keyword

Colonic neoplasms; Screening; High risk

MeSH Terms

Colon
Colonic Neoplasms
Colorectal Neoplasms*
Humans
Incidence
Life Style
Mass Screening*
Polyps
Prevalence
Risk Factors

Reference

1. Jung KW, Won YJ, Oh CM, Kong HJ, Lee DH, Lee KH. Community of Population-Based Regional Cancer Registries. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2014. Cancer Res Treat. 2017; 49:292–305.
Article
2. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, Dash C, Giardiello FM, Glick S, Johnson D, Johnson CD, Levin TR, Pickhardt PJ, Rex DK, Smith RA, Thorson A, Winawer SJ. American Cancer Society Colorectal Cancer Advisory Group. US Multi-Society Task Force. American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008; 134:1570–1595.
Article
3. Suh M, Song S, Cho HN, Park B, Jun JK, Choi E, Kim Y, Choi KS. Trends in participation rates for the national cancer screening program in Korea, 2002-2012. Cancer Res Treat. 2017; 49:798–806.
Article
4. Nishihara R, Wu K, Lochhead P, Morikawa T, Liao X, Qian ZR, Inamura K, Kim SA, Kuchiba A, Yamauchi M, Imamura Y, Willett WC, Rosner BA, Fuchs CS, Giovannucci E, Ogino S, Chan AT. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med. 2013; 369:1095–1105.
Article
5. Siegel RL, Fedewa SA, Anderson WF, Miller KD, Ma J, Rosenberg PS, Jemal A. Colorectal cancer incidence patterns in the United States, 1974-2013. J Natl Cancer Inst. 2017; 109. [Epub]. DOI: 10.1093/jnci/djw322.
Article
6. Kim DH, Cha JM, Lee JI, Joo KR, Shin HP, Park JJ, Jeon JW, Lim JU, Jun SJ, Seo YJ. Clinicopathological characteristics of colorectal cancer according to gender difference. Intest Res. 2012; 10:365–371.
Article
7. Graff RE, Moller S, Passarelli MN, Witte JS, Skytthe A, Christensen K, Tan Q, Adami HO, Czene K, Harris JR, Pukkala E, Kaprio J, Giovannucci EL, Mucci LA, Hjelmborg JB. Familial risk and heritability of colorectal cancer in the nordic twin study of cancer. Clin Gastroenterol Hepatol. 2017; 15:1256–1264.
Article
8. Schoen RE, Pinsky PF, Weissfeld JL, Yokochi LA, Church T, Laiyemo AO, Bresalier R, Andriole GL, Buys SS, Crawford ED, Fouad MN, Isaacs C, Johnson CC, Reding DJ, O'Brien B, Carrick DM, Wright P, Riley TL, Purdue MP, Izmirlian G, Kramer BS, Miller AB, Gohagan JK, Prorok PC, Berg CD. PLCO Project Team. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012; 366:2345–2357.
Article
9. Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol. 2001; 96:2992–3003.
Article
10. Taylor DP, Burt RW, Williams MS, Haug PJ, Cannon-Albright LA. Population-based family history-specific risks for colorectal cancer: a constellation approach. Gastroenterology. 2010; 138:877–885.
Article
11. Wong MC, Ching JY, Chiu HM, Wu KC, Rerknimitr R, Li J, Wu DC, Goh KL, Matsuda T, Kim HS, Leong R, Yeoh KG, Chong VH, Sollano JD, Ahmed F, Menon J, Ng SC, Wu JC, Chan FK, Sung JJ. Risk of colorectal neoplasia in individuals with self-reported family history: a prospective colonoscopy study from 16 Asia-Pacific regions. Am J Gastroenterol. 2016; 111:1621–1629.
Article
12. Kahi CJ, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Lieberman D, Levin TR, Robertson DJ, Rex DK. Colonoscopy surveillance after colorectal cancer resection: recommendations of the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2016; 111:337–346.
Article
13. Annese V, Beaugerie L, Egan L, Biancone L, Bolling C, Bran-dts C, Dierickx D, Dummer R, Fiorino G, Gornet JM, Higgins P, Katsanos KH, Nissen L, Pellino G, Rogler G, Scaldaferri F, Szymanska E, Eliakim R. ECCO. European evidence-based consensus: inflammatory bowel disease and malignancies. J Crohns Colitis. 2015; 9:945–965.
Article
14. Jess T, Rungoe C, Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol. 2012; 10:639–645.
Article
15. Bopanna S, Roy M, Das P, Dattagupta S, Sreenivas V, Mouli VP, Kedia S, Dhingra R, Pradhan R, Kumar NS, Yadav DP, Makharia G, Ahuja V. Role of random biopsies in surveillance of dysplasia in ulcerative colitis patients with high risk of colorectal cancer. Intest Res. 2016; 14:264–269.
Article
16. Watanabe T, Ajioka Y, Mitsuyama K, Watanabe K, Hanai H, Nakase H, Kunisaki R, Matsuda K, Iwakiri R, Hida N, Tanaka S, Takeuchi Y, Ohtsuka K, Murakami K, Kobayashi K, Iwao Y, Nagahori M, Iizuka B, Hata K, Igarashi M, Hirata I, Kudo SE, Matsumoto T, Ueno F, Watanabe G, Ikegami M, Ito Y, Oba K, Inoue E, Tomotsugu N, Takebayashi T, Sugihara K, Suzuki Y, Watanabe M, Hibi T. Comparison of targeted vs random biopsies for surveillance of ulcerative colitis-associated colorectal cancer. Gastroenterology. 2016; 151:1122–1130.
Article
17. Syngal S, Brand RE, Church JM, Giardiello FM, Hampel HL, Burt RW. American College of Gastroenterology. ACG clinical guideline: genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol. 2015; 110:223–262.
Article
18. Giardiello FM, Allen JI, Axilbund JE, Boland CR, Burke CA, Burt RW, Church JM, Dominitz JA, Johnson DA, Kaltenbach T, Levin TR, Lieberman DA, Robertson DJ, Syngal S, Rex DK. Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Dis Colon Rectum. 2014; 57:1025–1048.
19. Chung YW, Han DS, Park KH, Eun CS, Yoo KS, Park CK. Insulin therapy and colorectal adenoma risk among patients with type 2 diabetes mellitus: a case-control study in Korea. Dis Colon Rectum. 2008; 51:593–597.
Article
20. Liang PS, Chen TY, Giovannucci E. Cigarette smoking and colorectal cancer incidence and mortality: systematic review and meta-analysis. Int J Cancer. 2009; 124:2406–2415.
Article
21. Fedirko V, Tramacere I, Bagnardi V, Rota M, Scotti L, Islami F, Negri E, Straif K, Romieu I, La Vecchia C, Boffetta P, Jenab M. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol. 2011; 22:1958–1972.
Article
22. Jiang Y, Ben Q, Shen H, Lu W, Zhang Y, Zhu J. Diabetes mellitus and incidence and mortality of colorectal cancer: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 2011; 26:863–876.
Article
23. Chiu HM, Ching JY, Wu KC, Rerknimitr R, Li J, Wu DC, Goh KL, Matsuda T, Kim HS, Leong R, Yeoh KG, Chong VH, Sollano JD, Ahmed F, Menon J, Sung JJ. Asia-Pacific Working Group on Colorectal Cancer. A risk-scoring system combined with a fecal immunochemical test is effective in screening high-risk subjects for early colonoscopy to detect advanced colorectal neoplasms. Gastroenterology. 2016; 150:617–625.
Article
24. Cha JM, Han DS, Lee HL, Kim YH, Chung IK, Kim HS, Moon JS, Cho YK. Endoscopist specialty is associated with high-quality endoscopy in Korea. Yonsei Med J. 2012; 53:310–317.
Article
25. Lee JM, Kang YJ, Kim ES, Lee YJ, Park KS, Cho KB, Jeon SW, Jung MK, Lee HS, Kim EY, Jung JT, Jang BI, Kim KO, Chung YJ, Yang CH. Daegu-Gyeongbuk Gastrointestinal Study Group (DGSG). A wide variation of the quality of colonoscopy reporting system in the real clinical practice in southeastern area of Korea. Intest Res. 2016; 14:351–357.
Article
26. Lee CK, Choi KS, Eun CS, Park DI, Han DS, Yoon M, Suh M, Jun JK. Risk and characteristics of postcolonoscopy interval colorectal cancer after a positive fecal test: a nationwide population-based study in Korea. Cancer Res Treat. 2017; 02. 24. [Epub]. DOI: 10.4143/crt.2017.027.
Article
Full Text Links
  • JKMA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr